About Index Trending news
Analyze
Pricing
Ambrx

Ambrx

Ambrx

Ambrx is a biopharmaceutical company that develops protein therapeutics.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital
$45,000,000
Apricot Capital, HOPU Investment Management Company, Fosun Pharma, +4
Venture capital (Series D)
$10,000,000
Employees

Team size

50+
$45,000,000 Venture capital
FinSMEs

Ambrx Closes $45M Financing Round

Funding Health